Browse the complete record of transactions filed by Encrantz Staffan, Director. Insider active across 1 companies, notably Sight Sciences, Inc.. Aggregated, 7 reports have been recorded. Total volume traded: €24.6m. The latest transaction was filed on 13 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Staffan Encrantz is a Director at Sight Sciences, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. Encrantz brings valuable insight through his experience in the healthcare sector, thereby contributing to the governance and direction of the company.